VBI-2905a
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VBI-2905a, covering 2024-05-17 to 2024-05-17. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, and Immunogenicity of the COVID-19 Vaccine Candidates VBI-2902a and VBI-2905a [Phase 1]